Navigation Links
MAP Pharmaceuticals Provides Update on LEVADEX® Program
Date:4/12/2012

MOUNTAIN VIEW, Calif., April 12, 2012 /PRNewswire/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today provided an update on LEVADEX®, the Company's investigational orally inhaled drug for the potential acute treatment of migraine in adults.

  • The Company submitted a request to the U.S. Food and Drug Administration (FDA) for a meeting to discuss the Complete Response letter received on March 26, 2012. The Company announced that the FDA has scheduled a meeting with the Company, to occur in the second quarter.
  • On April 3, 2012, the United States Patent and Trademark Office (USPTO) issued to the Company U.S. Patent No. 8,148,377, titled "Method of Therapeutic Administration of DHE to Enable Rapid Relief of Migraine While Minimizing Side Effect Profile." This new patent, which expires in 2028, is the third in a series of patents issued to the Company relating to the pharmacokinetics of LEVADEX. The new patent results from the Company's discovery that dihydroergotamine (DHE) can be administered to achieve pharmacokinetic profiles of DHE that result in rapid efficacy while minimizing side effects that are typically seen with other migraine drugs.  

"We are pleased that the FDA has scheduled a meeting with us to discuss the issues contained in the Complete Response letter for LEVADEX," said Timothy S. Nelson, president and chief executive officer of MAP Pharmaceuticals. "We continue to work closely together with our partner, Allergan, as we seek to resolve the issues in the Complete Response letter as quickly as possible."

About MAP Pharmaceuticals

MAP Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing new therapies to address undermet patient needs in neurology. The Company is developing LEVADEX®, an orally inhaled investigational drug for the poten
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  A recently published ... Houston, Texas , demonstrates that 3D ... increasing cancer detection. The study, "Implementation ... Observational Study," was led by Stephen L. ... issue of the American Journal of Roentgenology ...
(Date:5/23/2013)... 23, 2013 More than half of women ... from chemotherapy and still have excellent outcomes. To educate ... of the largest sources of online consumer information about ... Facebook page provide recently diagnosed women with information sources, ... chemotherapy. "We anticipate these innovative social media ...
(Date:5/23/2013)... -- Every day, their baby stopped breathing, his collapsed bronchus blocking ... April and Bryan Gionfriddo watched helplessly, just praying ... a few doctors said he had a good chance of ... , about her now 20-month-old son, Kaiba. "At that ... take it and run with it." They found ...
Breaking Medicine Technology:First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4
... Feb. 27, 2012  The presidents of Chapman University and ... a joint School of BioPharmacy, initially launching at the ... on preparing graduate pharmacists for professions in biotechnology and ... practice. The school will open in fall 2014, pending ...
... Feb. 27, 2012 /PRNewswire-iReach/ -- TwinMed, LLC ... PrimeCare, Inc. and H.Eric Richard, Inc. (collectively "PrimeCare"), a ... distribution centers in Massachusetts and Maine. ... and it will substantially increase our base of service ...
Cached Medicine Technology:Innovative School of BioPharmacy to Open in Fall 2014 2Innovative School of BioPharmacy to Open in Fall 2014 3
(Date:5/25/2013)... The current residents of Back2Basics - Long ... B2B staff all came together Saturday, May 18th to celebrate ... Indian Cuisine, the residents got up to thank Roy Duprez, ... their road to recovery, and giving them a second chance ... in 2010 after realizing the need for a long-term facility. ...
(Date:5/24/2013)... 25, 2013 The special 35% off ... products from Sublime Beauty®. The products include a ... and many of the ingredients are in fact organic. ... is dreaded by many women," says Kathy Heshelow, founder ... women can diminish their cellulite." The plan includes two ...
(Date:5/24/2013)... 24, 2013 ShopPharmacyCounter.com PhenObestin 37.5 Summer ... have announced price reductions on their popular PhenObestin 37.5 ... helps clients to lose weight as effortlessly as possible ... by more than 50%. , Bottles have been reduced ... and all orders will receive free shipping. , ...
(Date:5/24/2013)... This week is National EMS Week, which ... provide the best emergency care and to improve health ... also to educate the public that all can play ... the first link, and a very important one. According ... a cardiac arrest can triple a victim’s chance of ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 ResortQuest Real ... joined the Dayna Feher team at the firm’s Bethany ... the Delaware resorts her home in 1975. Her real ... worked in all aspects of the real estate business ... the past 12 years, a licensed sales associate. ...
Breaking Medicine News(10 mins):Health News:Back2Basics Drug and Alcohol Rehabilitation Center Celebrates Their 3rd Anniversary 2Health News:"Get Ready for Summer Sale" at Sublime Beauty® Continues: New Cellulite Whisperer® Products 2Health News:ShopPharmacyCounter.com PhenObestin 37.5 Summer Sale Now On 2Health News:Acadian Medics Reunite with Miracle Baby 2Health News:Tammy Mushrush Joins ResortQuest Real Estate® and the Dayna Feher Team 2
... with seizures, PORTLAND, Oregon, June 18 The ... be,held this Sunday, June 22 in Portland at Waterfront ... event will take place from 9:30 am-12:30 pm., ... support people,living with epilepsy," said Alta Hancock, Associate Director. ...
... punch to fight tumors. Often, tumors have more than one ... enough. Now, in a new study, University of Missouri researchers ... cancer cells, by combining a small molecular drug that targets ... tumor blood vessels. , In 50 percent of breast cancer ...
... Martin promoted to lead College Living Experience, ... (ESA) today announced Stephanie Martin has been appointed ... (CLE), an ESA,program that helps students with autism ... be responsible for all operations, clinical, behavioral and,curricular ...
... at the Quicken Loans Arena on June 18th -- Join FIT 4 ... ... James and Mayor Frank Jackson,invite Cleveland residents to join a new program ... a FREE,health and fitness plan -- the Cleveland City Challenge. The city ...
... Infrastructure and Skilled Manpower Support Cutting-Edge ... Manufacturing ... firmly,established itself as a leading manufacturing hub in Asia with ... biomedical sciences manufacturing output expanded,four-fold from US$4.4 billion in 2000 ...
... Controls Adds to SAND,s ... ... (OTC,Bulletin Board: SNDTF), an international provider of intelligent enterprise,information management ... as Chief Financial Officer and Vice President, Finance,and Administration. The ...
Cached Medicine News:Health News:New cancer treatment targets both tumor cells and blood vessels 2Health News:Educational Services of America Names a New Senior VP of Operations 2Health News:NBA All-Star and Olympic Athlete LeBron James and Dr. Ian Smith Celebrate the Launch of The 50 Million Pound Challenge's First 'Citywide Team Challenge,' Kicking off in Cleveland, Ohio 2Health News:NBA All-Star and Olympic Athlete LeBron James and Dr. Ian Smith Celebrate the Launch of The 50 Million Pound Challenge's First 'Citywide Team Challenge,' Kicking off in Cleveland, Ohio 3Health News:Singapore Reinforces Position as a Global Site for Pharma & Biotech; Biomedical Manufacturing Output Quadruples to Reach US$17 Billion 2Health News:Singapore Reinforces Position as a Global Site for Pharma & Biotech; Biomedical Manufacturing Output Quadruples to Reach US$17 Billion 3Health News:Singapore Reinforces Position as a Global Site for Pharma & Biotech; Biomedical Manufacturing Output Quadruples to Reach US$17 Billion 4Health News:SAND Technology Appoints Zainab Ahmed Schwartz as CFO 2
... Farnsworth D15 test is ... strong color defect vs normal. ... boxes which permit the patient ... chips. Then the box is ...
... HRR 4th edition pseudoisochromatic test from Richmond ... screener plates and the 14 diagnostic series for ... plates has its own tab for easy and ... set of instructions in English and a laminated ...
Accepted by leading authorities as a simple and accurate method for discovering congenital color blindness of two type total color blindness and red/green blindness. This book is used for children an...
Stainless steel disposable retinal MVR blade, 10 pcs / box....
Medicine Products: